Medscape15h
Popular Weight Loss Drugs Now for Patients With Cancer?
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.
WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...
Weight-loss drugs are supposed to be forever. Until they run out.
Maez Waibel lost more than 30 pounds in nine months on the new weight-loss drugs, sparking a substantial improvement in ...
New weight loss drugs could be developed much faster if Roche gets its way
Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
A doctor shares how his patients are trying to afford weight-loss drugs — and what happens if they can't
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...
Benzinga (Video) on MSN9h
WeightWatchers CEO As Popular Weight Loss Drugs Disrupt Industry
WeightWatchers announced the departure of CEO Sima Sistani, effective immediately, and board member Tara Comonte, former ...
health.wusf.usf.edu2h
WeightWatchers drops CEO who led company's move into weight-loss drugs
In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...
Opinion
The Columbian15hOpinion
Jarvis: High weight loss drug costs hurt
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...